G8 Automated HPLC Analyzer - 723G8 Product Usage - In vitro diagnostic use for the quantitativ...

FDA Device Recall #Z-3244-2018 — Class II — July 13, 2018

Recall Summary

Recall Number Z-3244-2018
Classification Class II — Moderate risk
Date Initiated July 13, 2018
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Tosoh Bioscience Inc
Location Grove City, OH
Product Type Devices
Quantity 8 units

Product Description

G8 Automated HPLC Analyzer - 723G8 Product Usage - In vitro diagnostic use for the quantitative measurement of % hemoglobin A1c in whole blood specimens. This test is to be used as an aid in the diagnosis of diabetes and as an aid in identifying patients who may be at risk for developing diabetes.

Reason for Recall

Analyzers were distributed with software which lacks a 510K

Distribution Pattern

US Nationwide Distribution in states of - CA, OK, VA 7 WI

Lot / Code Information

Serial Numbers: 14646304, 14917201, 14886112, 14616503, 14856212, 14887601, 14886212 & 14917201

Other Recalls from Tosoh Bioscience Inc

Recall # Classification Product Date
Z-2968-2020 Class II Tosoh Bioscience AIA-PACK BHCG Calibration Veri... Aug 7, 2020
Z-2967-2020 Class II Tosoh Bioscience AIA- PACK HCG Calibrator Set-I... Aug 7, 2020
Z-2423-2020 Class II AIA-900 Analyzer, Part no. 022930, UDI 04560189... May 22, 2020
Z-1420-2020 Class II AIA-360 Automated Immunoassay Analyzer, Product... Jan 10, 2020
Z-0675-2019 Class II ST AIA-PACK Homocysteine (HCY) is designed for ... Nov 30, 2018

Frequently Asked Questions

A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.